Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amgen Australia is the local subsidiary of Amgen Inc., one of the world's leading independent biotechnology companies. Based in Sydney, the company focuses on delivering innovative human therapeutics for patients with serious illnesses in areas such as oncology, hematology, cardiovascular disease, and bone health. Amgen Australia plays a significant role in the global clinical development program, conducting numerous clinical trials across the country. The company is responsible for the commercialization and distribution of a robust portfolio of biologics and small molecule medicines within the Australian healthcare system. It is committed to advancing science and improving patient access to life-changing treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amgen Australia.